CD8A and metastatic malignant neoplasm: Furthermore, nPKC-θ is enriched in CD8+ T cells isolated from metastatic cancer patients resistant to immunotherapy treatment, where it is complexed with ZEB1, a key repressive transcription factor in EMT.